We rank companies based on fund manager, research analyst and news sentiment
HELX

Franklin Genomic Advancements ETF
HELX

$29.46
0.64%
0
Funds holding %
of 6,474 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

291% more capital invested

Capital invested by funds: $1.1M [Q3] → $4.29M (+$3.19M) [Q4]

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

27.33% more ownership

Funds ownership: 12.91% [Q3] → 40.23% (+27.33%) [Q4]

25% more funds holding

Funds holding: 8 [Q3] → 10 (+2) [Q4]

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Research analyst outlook

We haven’t received any recent analyst ratings for HELX.

Financial journalist opinion

We haven’t received any recent news articles for HELX.